After the Fed released minutes of its last meeting, the bond market signaled it fears the Fed will not be aggressive enough with its rate cutting.Market Insiderread more
Analysts generally doubt how effective the People Bank of China's latest interest rate announcement will be in significantly helping businesses grow.China Economyread more
The Fed minutes also note that "a couple" members wanted a 50 basis point cut, based primarily on the weak inflation readings.The Fedread more
Flight bookings to Hong Kong have fallen 10%, hit by the unrest in the city, said Alan Joyce, the chief executive of Australian carrier Qantas Airways.Airlinesread more
Japanese manufacturing activity shrank for a fourth straight month in August as export orders fell at a sharper pace.Asia Marketsread more
These in-demand skills can command top pay packets, says Feon Ang of professional networking site LinkedIn.Get Aheadread more
The Washington governor had centered his campaign around climate change, calling it "the most urgent challenge of our time."Politicsread more
The inversion is seen by many veteran traders as an important recession omen, though the timing on the eventual downturn is less predictable.Bondsread more
Here's what Nordstrom reported for its fiscal second-quarter earnings.Retailread more
The sexy image that once boosted Victoria's Secret has been haunting L Brands more recently, as women are steering clear of the brand's hot pink, lacy and bejeweled lingerie.Retailread more
Ford is one of four automakers that reached a voluntary agreement with California on fuel efficiency rules, defying Trump and his administration's effort to strip the state of...Autosread more
Price is what you pay, but value, as Warren Buffett has observed, is what you get.
Lately, big-name investors like Bill Miller and Aswath Damodaran are betting they'll get more than they paid for out of shares of troubled Valeant Pharmaceuticals International, which on Monday named new leadership.
Both built positions in Valeant when it was trading around $32 a share, compared with its all-time closing high of $263 last August.
The company's deep and dramatic sell-off is a key part of their attraction. "It's probably the most toxic name in the market," Miller told CNBC's "Closing Bell " on Friday.
Valeant's share prices were up about 3 percent Monday, after the company named Joseph Papa to succeed Michael Pearson as chairman and chief executive. The company said Papa, the 60-year-old chairman and CEO of drug company Perrigo, is expected to join Valeant early next month.